Headline
The latest stories from AHA Today.
The AHA, American Medical Association, American Society of Anesthesiologists, American Society of Health-System Pharmacists, and Association for Clinical Oncology are urging the Drug Enforcement Agency to allow drug manufacturers and 503B outsourcing facilities to receive increased annual…
Given the scarcity of the ventilators in the Strategic National Stockpile and the current capacity of the private sector to meet the demand, the Federal Emergency Management Agency has adopted a new process to manage federal ventilator resources to ensure the ventilators are shipped to the states…
The Food and Drug Administration announced it is requesting manufacturers immediately withdraw all prescription and over-the-counter ranitidine drugs (commonly known by the brand name Zantac) from the market.
The Federal Emergency Management Agency and Department of Health and Human Services have created a Supply Chain Stabilization Task Force to address the need for personal protective equipment, ventilators and other life-saving equipment.
The AHA released a Special Bulletin with information and FAQs on the Federal Reserve emergency lending program included in the Coronavirus Aid, Relief and Economic Security (CARES) Act.
Vice President Pence, on behalf of President Trump and the White House Coronavirus Task Force, sent a letter to the nation's hospitals requesting that all hospitals report certain data on COVID-19 testing results, bed and ventilator capacity.
The Centers for Medicare & Medicaid Services released a substantial number of new waivers related to COVID-19. The waivers apply nationwide and are retroactive to March 1, 2020.
AHA asked the Department of Health and Human Services and Centers for Medicare & Medicaid Services to directly and expediently distribute to rural and urban hospitals and health systems funds from the Public Health and Social Services Emergency Fund that were designated for providers in the…
The Joint Commission has issued a new standards FAQ on monitoring patients at high risk for suicide who have known or suspected COVID-19.
The Partnership to Amend 42 CFR Part 2, a coalition of nearly 50 health care organizations including the AHA, applauded Congress’ important step to modernize privacy regulations affecting the disclosure of patients’ substance use disorder treatment records.